| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/29/2003 | US6555651 Ligand binding site of rage and uses thereof |
| 04/29/2003 | US6555520 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and immunologicval disorders |
| 04/29/2003 | US6555373 Methods for identifying human cell lines useful for endogenous gene activation isolated human cell lines identified thereby, and uses thereof |
| 04/29/2003 | US6555366 Coding for a specific protein of interest in bacillus strains |
| 04/29/2003 | US6555352 Peptide for use in human therapeutics and diagnostic compositions |
| 04/29/2003 | US6555346 Selecting a recombinant baculovirus expressing the protein, growing insect cells in a culture vessel and infecting the cells with an inoculum of baculovirus at a cell density of 1 x 105-5 x 106 cells/ml |
| 04/29/2003 | US6555345 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 04/29/2003 | US6555342 Fusion protein delivery system and uses thereof |
| 04/29/2003 | US6555338 Given nucleotide sequence; use of polynucleotides and polypeptides in diagnostic assays, and possibly functional genomics |
| 04/29/2003 | US6555336 From a starting material containing albumin in concentrated or isolated form; efficiency |
| 04/29/2003 | US6555327 Monoclonal antibodies against S100 |
| 04/29/2003 | US6555319 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 04/29/2003 | US6555313 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 04/29/2003 | US6555116 Hypo-allergenic pollen protein that has been treated with thioredoxin, nicotinamide adenine dinucleotide phosphate-thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH). |
| 04/29/2003 | US6555113 Elevating the ratio of circulating HDL to circulating LDL by administering a peptide conjugate of a helper T cell epitope portion linked to a B cell epitope portion; decrease in development of atherosclerotic lesions |
| 04/29/2003 | US6555112 Peptides derived from the lymphadenopathy-associated virus (LAV) envelope coding region |
| 04/29/2003 | US6555107 Packaging cell |
| 04/29/2003 | US6555105 Method of treatment with a RANTES antagonist polypeptide |
| 04/29/2003 | CA2258502C Modified factor viii |
| 04/29/2003 | CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 04/29/2003 | CA2105804C Kainate-binding, human cns receptors of the eaa5 family |
| 04/29/2003 | CA2102208C Binding domains in notch and delta proteins |
| 04/29/2003 | CA1341428C Synthetic insecticidal crystal protein gene |
| 04/24/2003 | WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides |
| 04/24/2003 | WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | WO2003033719A1 Cell-free protein synthesis means |
| 04/24/2003 | WO2003033699A2 Production, detection and use of transformant cells |
| 04/24/2003 | WO2003033697A1 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 04/24/2003 | WO2003033695A1 Method of purifying recombinant fused protein and method of producing protein using the same |
| 04/24/2003 | WO2003033680A2 Kinases and phosphatases |
| 04/24/2003 | WO2003033677A2 Dimerized growth factor and materials and methods for producing it |
| 04/24/2003 | WO2003033674A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/24/2003 | WO2003033666A2 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 04/24/2003 | WO2003033662A2 Protection against oxidative stress and inflammation by a cytoprotective response element |
| 04/24/2003 | WO2003033654A2 Direct targeting binding proteins |
| 04/24/2003 | WO2003033653A2 Affinity enhancement agents |
| 04/24/2003 | WO2003033650A2 Recombinant renilla reniformis system for bioluminescence resonance energy transfer |
| 04/24/2003 | WO2003033580A2 Non-degradable and degradable porous materials with high surface areas |
| 04/24/2003 | WO2003033538A1 Anti-hla-dr antibody |
| 04/24/2003 | WO2003033537A1 Process for the production of egg yolk antibodies against organochlorine pesticides |
| 04/24/2003 | WO2003033522A1 Isolation of lectins |
| 04/24/2003 | WO2003033521A1 Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides. |
| 04/24/2003 | WO2003033021A1 Use of peptide vectors to improve the immune response to antigens |
| 04/24/2003 | WO2003032898A2 Modified human thymic stromal lymphopoietin |
| 04/24/2003 | WO2003032814A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 04/24/2003 | WO2003032813A2 Methods for the treatment of carcinoma |
| 04/24/2003 | WO2003032810A2 Treatment and diagnosis of insulin resistant states |
| 04/24/2003 | WO2002088706A3 Process for differential diagnosis of alzheimer's dementia and device therefor |
| 04/24/2003 | WO2002074959A3 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1 |
| 04/24/2003 | WO2002055552A3 Soluble cyclic analogues of beta amyloid peptide |
| 04/24/2003 | WO2002052029A9 Process for producing recombinant protein and fused protein |
| 04/24/2003 | WO2002050120A3 High affinity antibodies |
| 04/24/2003 | WO2002046383A3 Protein modification and maintenance molecules |
| 04/24/2003 | WO2002046227A3 Glp-1 fusion proteins |
| 04/24/2003 | WO2002040688A3 Maize yellow stripe1 and related genes |
| 04/24/2003 | WO2002036801A3 Extruded protein hydrolysate, method for production and use thereof |
| 04/24/2003 | WO2002026825A3 G-protein coupled receptors |
| 04/24/2003 | WO2002004513A3 Down syndrome critical region 1-like 1 proteins |
| 04/24/2003 | WO2001077389A3 Genes expressed in foam cell differentiation |
| 04/24/2003 | US20030079253 Immunoglobulin binding protein arrays in eukaryotic cells |
| 04/24/2003 | US20030079237 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 04/24/2003 | US20030078409 Nucleotide sequences coding polypeptide for use in the treatment of respiratory system, asthmatic and inflammatory bowel diseases |
| 04/24/2003 | US20030078405 47 human secreted proteins |
| 04/24/2003 | US20030078402 Expression library for use in the generation of preferential immunoglobulins |
| 04/24/2003 | US20030078391 Nucleotide sequences coding polypeptide for use in treatment of periodontal disease |
| 04/24/2003 | US20030078390 Tissue cement proteins from Rhipicephalus appendiculatus |
| 04/24/2003 | US20030078389 Gamma-heregulin |
| 04/24/2003 | US20030078386 Antibody for use in the treatment of viral, gastrointestinal, autoimmune and cell proiferative disorders |
| 04/24/2003 | US20030078385 Method for making multispecific antibodies having heteromultimeric and common components |
| 04/24/2003 | US20030078382 Human Ect2 and methods of use |
| 04/24/2003 | US20030078380 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030078379 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030078377 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030078376 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 04/24/2003 | US20030078373 Chaperone fragments |
| 04/24/2003 | US20030078370 Antibodies to cyclin E2 protein |
| 04/24/2003 | US20030078197 For treatment of leukemia; enhancing bone marrow recovery in allogeneic or autologous transplantation and in treatment, radiation, chemically, or chemotherapeutically induced aplasia or myelosuppression |
| 04/24/2003 | US20030077809 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and skin disorders |
| 04/24/2003 | US20030077808 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer |
| 04/24/2003 | US20030077805 Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof |
| 04/24/2003 | US20030077792 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077791 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077790 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077788 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077787 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077786 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077785 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077784 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077783 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077782 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077781 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077780 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 04/24/2003 | US20030077779 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077778 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077777 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077776 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077768 Oxidation of a substituted polycyclic aromatic substrate; provide genetically engineered microorganism, incubate with aromatic substrate, culture microrganism, recover oxidized substrate |
| 04/24/2003 | US20030077758 Myc repressor modulation to treat aging-related disorders |
| 04/24/2003 | US20030077757 Method of treating aging-related disorders |